Carter Allen, PhD, is a Senior Research Advisor in Discovery Statistics at Eli Lilly and Company, where they utilize advanced computational methods and genomic data to investigate diseases related to neurodegeneration, pain, and addiction. Previously, Carter served as a Graduate Research Associate at The Ohio State University Wexner Medical Center, providing statistical and bioinformatic support for cancer studies and COVID-19 trials. Their academic background includes a PhD in Biomedical Sciences from The Ohio State University and ongoing studies for a Bachelor of Science in Statistics at the University of South Carolina. Carter's early experience includes internships in water quality and sustainability, where they developed statistical models and led collaborative projects in Charleston, SC.
This person is not in the org chart
This person is not in any teams
This person is not in any offices